The Neuroprotective Effects of DPP-4 and SGLT2 Inhibitors in Type 2 Diabetes: Possible Mechanism for Halting Cognitive Deterioration

被引：0
|
作者：
Osman, Shams T. [1 ]
Hamdy, Noha A. [1 ]
El Feky, Amr Y. [2 ]
El-Khordagui, Labiba K. [1 ]
El-Yazbi, Ahmed F. [3 ]
机构：
[1] Alexandria Univ, Fac Pharm, Alexandria, Egypt
[2] Alexandria Univ, Fac Med, Alexandria, Egypt
[3] Alexandria Univ, Alexandria, Egypt
来源：
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 2023年 / 385卷
关键词：
D O I：
10.1124/jpet.122.138010
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
256
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Role of DPP-4 and SGLT2 Inhibitors Connected to Alzheimer Disease in Type 2 Diabetes Mellitus
    Sim, A. Young
    Barua, Sumit
    Kim, Jong Youl
    Lee, Yong-ho
    Lee, Jong Eun
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [2] Efficacy/safety balance of DPP-4 inhibitors versus SGLT2 inhibitors in elderly patients with type 2 diabetes
    Scheen, Andre J.
    DIABETES & METABOLISM, 2021, 47 (06)
  • [3] In type 2 diabetes, SGLT2 inhibitors were linked to diabetic ketoacidosis vs. DPP-4 inhibitors
    Liakos, Aris
    Tsapas, Apostolos
    Bekiari, Eleni
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (12) : JC70 - JC70
  • [4] Type 2 Diabetes: SGLT2 Inhibitors and DPP4 Inhibitors in Comparison
    Simon, Annika
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (16) : 1002 - 1002
  • [5] Risk of hyperkalaemia in patients with type 2 diabetes mellitus prescribed with SGLT2 versus DPP-4 inhibitors
    Wu, Mei-zhen
    Teng, Tiew-Hwa Katherine
    Tsang, Christopher Tze-Wei
    Chan, Yap-Hang
    Lee, Chi-Ho
    Ren, Qing-wen
    Huang, Jia-Yi
    Cheang, Iok-fai
    Tse, Yi-Kei
    Li, Xin-li
    Xu, Xin
    Tse, Hung-Fat
    Lam, Carolyn S. P.
    Yiu, Kai-Hang
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024, 10 (01) : 45 - 52
  • [6] Effects of SGLT2 Inhibitors and DPP-4 Inhibitors on Advanced Glycation End Products
    Kusunoki, Masataka
    Hisano, Fumiya
    Matsuda, Shin-ichi
    Kusunoki, Akiko
    Abe, Tomokazu
    Tsutsumi, Kazuhiko
    Miyata, Tetsuro
    DRUG RESEARCH, 2024, 74 (02) : 77 - 80
  • [7] SGLT2 versus DPP4 inhibitors for type 2 diabetes
    Scheen, Andre J.
    LANCET DIABETES & ENDOCRINOLOGY, 2013, 1 (03): : 168 - 170
  • [8] EFFECTS OF SGLT-2 INHIBITORS VERSUS DPP-4 INHIBITORS ON ANEMIA IN PATIENTS WITH TYPE 2 DIABETES
    Yang, Ai-Yu
    Chen, Hung-Chun
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1007 - I1008
  • [9] Association Between SGLT2 Inhibitors vs DPP-4 Inhibitors and Risk of Pneumonia Among Patients With Type 2 Diabetes
    Au, Philip C. M.
    Tan, Kathryn C. B.
    Cheung, Bernard M. Y.
    Wong, Ian C. K.
    Wong, Ying
    Cheung, Ching-Lung
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (04): : E1719 - E1726
  • [10] THE COMPARISON OF SGLT2 INHIBITORS AND DPP-4 INHIBITORS ON HEALTH CARE EXPENDITURE AND UTILIZATION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Wagner, T.
    Dixon, D. L.
    Salgado, T. M.
    VALUE IN HEALTH, 2020, 23 : S117 - S117
12345